ParcelBio

ParcelBio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://parcelbio.com

Last Round

Seed

May 7, 2026

Total Funding Raised

$13.5M

Company Overview

ParcelBio is a biotechnology company founded in 2023 by David Weinberg and Chris Carlson. The company is developing the next generation of RNA medicines through a programmable, nanoparticle-free delivery platform called 'STAmP' (Stabilization and Targeting by Annealing mRNA to ParcelOligos). This technology aims to safely and precisely deliver mRNA to specific cell types, overcoming the toxicity and targeting limitations of current methods. The company's initial focus is on developing treatments for kidney disorders, chronic liver diseases, and immune system dysregulation. A graduate of the Y Combinator (W24) accelerator, ParcelBio aims to partner with pharmaceutical and biotech companies to advance its therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

mRNA deliverynanoparticle-free deliverySTAmP platformtargeted drug deliveryLNP-free deliverylipid nanoparticle alternativeoligonucleotide deliveryprogrammable therapeuticsbeyond LNPtechnology partneringmRNA stabilizationbiotech licensingkidney disease therapeuticsliver disease therapeuticsCRISPR deliverygene editing delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ParcelBio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ParcelBio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMay 7, 2026
Seed RoundMar 4, 2026
SeedMay 9, 2024

Key People

Founding team and executive leadership

David Weinberg

Co-Founder And CEO

Founding Team

ParcelBio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 7, 2026

    $13M round led by Breyer Capital.

  • Mar 4, 2026

    $13.17M raised in Seed Round.

ParcelBio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ParcelBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ParcelBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range6
Year Founded2023
Last FundingMay 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.